Nadine M Tung (Nadine Tung)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Positive Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

JCO precision oncology

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Adrienne G Waks, Michelle DeMeo, Harold J Burstein, Ann H Partridge, Patrizia Dell'Orto, Leila Russo, Emma Krause, Daniel J Newhouse, Busem Binboğa Kurt, Elizabeth A Mittendorf, Bryan Paul Schneider, Adrienne G Waks, Eric P Winer, Ian E Krop, Sara M Tolaney, null null, null null
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nadine M Tung, Charité Ricker, Hans Messersmith, Judith Balmaña, Susan M Domchek, Elena Martinez Stoffel, Khaldoun Almhanna, Banu K Arun, Yanin Chavarri Guerra, Stephanie A Cohen, Deborah Cragun, Katherine D Crew, Michael J Hall, Gregory E Idos, Ghecemy Lopez, Tuya Pal, Sara Pirzadeh-Miller, Colin C Pritchard, Huma Q Rana, Umang Swami, Gregory A Vidal
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Adrienne G Waks, Emily L Chen, Noah Graham, Anna Mae Frey, Kenneth Almeida, Victoria Attaya, Victoria Attaya, Ibrahim M Abbass, Anita Fung, Jesse Sussell, Patricia Cortazar, Caroline Harvey, Denise Leth, Meredith Faggen, Natalie Sinclair, Jeanna Walsh, Nadine M Tung, Sarah Sinclair, Steve Lo, Denise Yardley, Vicente Valero, Jane Meisel, Tarah Jean Ballinger, Sylvia Adams, Lisa Anne Carey, Julia K Rauch, Vandana G Abramson, Nicole O Williams, Wendy Y Chen, José Pablo Leone, Susan T Schumer, Nabihah Tayob, Sara M Tolaney
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial). JCO oncology practice (2024)
Nadine M Tung, Charité Ricker, Hans Messersmith, Judith Balmaña, Susan M Domchek, Elena Martinez Stoffel, Khaldoun Almhanna, Banu K Arun, Yanin Chavarri Guerra, Stephanie A Cohen, Deborah Cragun, Katherine D Crew, Michael J Hall, Gregory E Idos, Ghecemy Lopez, Tuya Pal, Sara Pirzadeh-Miller, Colin C Pritchard, Huma Q Rana, Umang Swami, Gregory A Vidal
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charité Ricker, Banu K Arun, Sara Pirzadeh-Miller, Elena Martinez Stoffel, Hans Messersmith, Nadine M Tung
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights. JCO oncology practice (2024)
Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke M Lucassen, Nadine M Tung, Claudine Isaacs
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 7 (2023)
Felipe Batalini, Russell W Madison, Ethan S Sokol, Dexter X Jin, Kuei-Ting Chen, Brennan Decker, Dean C Pavlick, Garrett M Frampton, Gerburg M Wulf, Judy E Garber, Geoffrey R Oxnard, Alexa B Schrock, Nadine M Tung
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1 / 2 , Germline PALB2 , or Homologous Recombination Deficiency Signature. JCO precision oncology 7 (2023)
Emma Guyonnet, Shana J Kim, Yue Yin Xia, Vasily Giannakeas, Jan A Lubiński, Susan Randall Armel, Andrea F Eisen, Louise Bordeleau, Charis Eng, Olufunmilayo I Olopade, Nadine M Tung, William D Foulkes, Fergus J Couch, Amber M Aeilts, Steven A Narod, Joanne Kotsopoulos
Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation. Cancer research communications 3 (11) (2023)
Nadine M Tung, Judy E Garber
PARP inhibition in breast cancer: progress made and future hopes. NPJ breast cancer 8 (1) (2022)
Neelam V Desai, Dana Zakalik, Mark R Somerfield, Nadine M Tung
Q and A: A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer. JCO oncology practice 18 (6) (2022)
Junko Tsuji, Tianyu Li, Albert Grinshpun, Tim H H Coorens, Douglas Russo, Leilani Anderson, Rebecca Rees, Agostina Nardone, Candace Patterson, Niall J Lennon, Carrie Cibulskis, Ignaty Leshchiner, Nabihah Tayob, Sara M Tolaney, Nadine M Tung, Donald P McDonnell, Ian E Krop, Eric P Winer, Chip Stewart, Gad A Getz, Rinath M Jeselsohn
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Alison Schwartz Levine, Sophie R Hyman, Samantha M Stokes, Danielle Castillo, Nadine M Tung, Jeffrey N Weitzel, Huma Q Rana, Judy E Garber
Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants. JCO precision oncology 5 (2022)
Gabrielle Betty Rocque, Courtney J Andrews, Valerie M Lawhon, Rachel Frazier, Stacey A Ingram, Mary Lou Smith, Lynne I Wagner, Lisa Zubkoff, Nadine M Tung, Lauren P Wallner, Antonio C Wolff
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment. JCO oncology practice (2022)
Adrienne G Waks, Neelam V Desai, Tianyu Li, Philip D Poorvu, Ann H Partridge, Natalie Sinclair, Laura M Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M Rosenberg, Elizabeth Frank, Sara M Tolaney, Ian E Krop, Nadine M Tung, Nabihah Tayob, Tari A King, Elizabeth A Mittendorf, Eric P Winer
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer. NPJ breast cancer 8 (1) (2022)
Felipe Batalini, Doga C Gulhan, Victor Y Mao, Antuan V Tran, Madeline Polak, Niya Xiong, Nabihah Tayob, Nadine M Tung, Eric P Winer, Erica L Mayer, Stian Knappskog, Per Eystein Lønning, Ursula A Matulonis, Panagiotis A Konstantinopoulos, David B Solit, Helen H Won, Hans Petter Eikesdal, Peter J Park, Gerburg M Wulf
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Nadine M Tung, Dana Zakalik, Mark R Somerfield, null null
Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Sara M Tolaney, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Paul Schneider, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Yue Zheng, Shoshana M Rosenberg, Richard D Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann H Partridge, Eric P Winer, Ian E Krop
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Sara M Tolaney, Elizabeth Garrett-Mayer, Julia R White, Victoria S Blinder, Jared C Foster, Laleh Amiri-Kordestani, E Shelley Hwang, Judith M Bliss, Eileen Rakovitch, Jane Perlmutter, Patricia A Spears, Elizabeth Frank, Nadine M Tung, Anthony D Elias, David A Cameron, Neelima Denduluri, Ana F Best, Andrea Gombos, Lawrence Baizer, Lynn Pearson Butler, Elena Schwartz, Eric P Winer, Larissa A Korde
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Nadine M Tung, Neelam V Desai
Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, P Kelly Marcom, Payal Deepak Shah, Tarah J Ballinger, Eddy Shih-Hsin Yang, Shaveta Vinayak, Michelle E Melisko, Adam M Brufsky, Michelle DeMeo, Colby Jenkins, Susan M Domchek, Alan D' Andrea, Nancy U Lin, Melissa E Hughes, Lisa Anne Carey, Nikhil Wagle, Gerburg M Wulf, Ian E Krop, Antonio C Wolff, Eric P Winer, Judy E Garber
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Felipe Batalini, Ellie G Peacock, Lindsey Stobie, Alison Robertson, Judy Garber, Jeffrey N Weitzel, Nadine M Tung
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis. Breast cancer research : BCR 21 (1) (2019)